for DOC DAIMLER

Ardiana Hoxhaj

Centene Corporation

SMIP

Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. The company's Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and Medicare - Medicaid plans, which covers dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions, limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. Its Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; and vision and dental, and management services, as well as care management software that automate the clinical, administrative, and technical components of care management programs. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

Centene is a bit of an outlier among its health insurance peers. While the past few years have produced a cascade of insurer exits from Obamacare’s marketplaces — particularly amid uncertainty about the health law’s future and the Trump administration’s thousand cuts to the program — Centene has doubled down. And it’s paid off in spades. More than 1.4 million Americans signed up for Centene’s federal Affordable Care Act plans during the most recent open enrollment season, leading CEO Michael Neidorff to exclaim the firm “had planned on incremental growth, but not that much.” The company also has a growing footprint in the managed care market fueled by deals such as its $3.75 billion acquisition of Fidelis Care last fall.

“Shares of Centene Corp. CNC, +4.28% shot up 6.1% in premarket trade Tuesday after the health-care services company reported first-quarter profit and revenue that beat expectations and raised its full-year outlook. Net income rose to $522 million, or $1.24 a share, from $340 million, or 96 cents a share, in the year-ago period. Excluding non-recurring items, adjusted EPS was $1.39, above the FactSet consensus of $1.35. Total revenue rose 40% to $18.44 billion, beating the FactSet consensus of $17.46 billion, as Medicaid revenue jumped 54% to $12.61 billion, Medicare revenue increased 19% to $1.38 billion and commercial revenue rose 19% to $3.65 billion. For 2019, the company raised its adjusted EPS guidance to $4.24 to $4.44 from $4.11 to $4.31 and its revenue outlook to $72.8 billion to $73.6 billion from $70.3 billion to $71.1 billion. The stock, which closed at a 17-month low last Wednesday amid a broad selloff in the health care sector, has tumbled 23.4% over the past three months through Monday, while the SPDR Health Care Select Sector ETF XLV, +0.83% has lost 4.0% and the S&P 500 SPX, +0.27% has gained 10.2%,” says Tomi Kilgore, publisher and editor. Historical index on US Stock Market: "Should I invest in Centene stock?" "Should I trade "CNC" stock today?" According to Live Forecast System, Centene Corporation stock is an awesome long-term (1-year) investment. "CNC" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "CNC" projections. At Walletinvestor.com, they predict future values with technical analysis for wide selection of stocks like Centene Corporation (CNC). If you are looking for stocks with good return, Centene Corporation can be a profitable investment option. Centene Corporation quote is equal to 52.270 USD at 2019-04-26. Based on our forecasts, a long-term increase is expected, the "CNC" stock price prognosis for 2024-04-16 is 143.263 USD. With a 5-year investment, the revenue is expected to be around +174.08%. So, your current $100 investment may be up to $274.08 in 2024.